Manuel A Baños-González, Antonio González-Hermosillo, Milton E Guevara-Valdivia, Jorge A Vázquez-Acosta, Manuel O de Los Ríos-Ibarra, Julio A Aguilar-Linares, Carlos Cantú-Brito, José L Leiva-Pons, Gerardo Pozas-Garza, Eddie A Favela-Pérez, Luis Molina, Reynaldo Magaña-Magaña, Rocío Camacho-Casillas, Eduardo Chuquiure-Valenzuela, Janneth Manzano-Cabada, Manlio F Márquez-Murillo
INTRODUCTION: Heart failure in patients with non-valvular atrial fibrillation (NVAF) is two to three times more common than in individuals without NVAF. OBJECTIVE: To identify cardiometabolic risk factors (CMRF) and antithrombotic treatment in patients with NVAF and heart failure with reduced ejection fraction (HFrEF), and to determine if there were differences according to gender. METHODS: CMRF, pro-thrombotic risk, bleeding risk, and antithrombotic therapy were globally analyzed and according to gender...
2023: Gaceta Médica de México